Biotech News
Phathom Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Business Update
Over 2 million total VOQUEZNA® prescriptions filled through October 16, 2026 Q3 2026 net revenues of $84.7 million increased 71% vs. Q3 2025 and 14% vs. Q2 2026 Generated positive operating cash flow for the second consecutive quarter Reaffirmed full-year 2026 financial guidance Conference call and
